Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Highly expressed centromere protein L indicates adverse survival and associates with immune infiltration in hepatocellular carcinoma. | Aging (Albany NY) | 2021 | 34607313 | PubTator, text mining | PubMed |
| Upregulation of ADAM12 Is Associated With a Poor Survival and Immune Cell Infiltration in Colon Adenocarcinoma. | Front Oncol | 2021 | 34604068 | PubTator, text mining | PubMed |
| CD177 modulates the function and homeostasis of tumor-infiltrating regulatory T cells. | Nat Commun | 2021 | 34599187 | PubTator, text mining | PubMed |
| Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2021 | 34595140 | PubTator, text mining | PubMed |
| The expression landscape of JAK1 and its potential as a biomarker for prognosis and immune infiltrates in NSCLC. | BMC Bioinformatics | 2021 | 34587898 | PubTator, text mining | PubMed |
| c-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis. | Clin Transl Med | 2021 | 34586738 | PubTator, text mining | PubMed |
| Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy. | Int J Mol Sci | 2021 | 34575965 | PubTator, text mining | PubMed |
| Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma. | Cancers (Basel) | 2021 | 34572949 | PubTator, text mining | PubMed |
| Tumor-Associated Macrophages in Bladder Cancer: Biological Role, Impact on Therapeutic Response and Perspectives for Immunotherapy. | Cancers (Basel) | 2021 | 34572939 | PubTator, text mining | PubMed |
| ALK-Negative Anaplastic Large Cell Lymphoma: Current Concepts and Molecular Pathogenesis of a Heterogeneous Group of Large T-Cell Lymphomas. | Cancers (Basel) | 2021 | 34572893 | PubTator, text mining | PubMed |
| Annexin A1 as a Regulator of Immune Response in Cancer. | Cells | 2021 | 34571894 | PubTator, text mining | PubMed |
| CD49a Identifies Polyfunctional Memory CD8 T Cell Subsets that Persist in the Lungs After Influenza Infection. | Front Immunol | 2021 | 34566986 | PubTator, text mining | PubMed |
| Overexpression of IRF3 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma. | Int J Gen Med | 2021 | 34557022 | PubTator, text mining | PubMed |
| PLAUR as a Potential Biomarker Associated with Immune Infiltration in Bladder Urothelial Carcinoma. | J Inflamm Res | 2021 | 34552345 | PubTator, text mining | PubMed |
| Single-cell profiling defines the prognostic benefit of CD39high tissue resident memory CD8+ T cells in luminal-like breast cancer. | Commun Biol | 2021 | 34552178 | PubTator, text mining | PubMed |
| Role of Toll-like receptors in natural killer cell function in acute lymphoblastic leukemia. | Oncol Lett | 2021 | 34539852 | PubTator, text mining | PubMed |
| Immune Dysregulation in IgG4-Related Disease. | Front Immunol | 2021 | 34539675 | PubTator, text mining | PubMed |
| STC1 is a Novel Biomarker Associated with Immune Characteristics and Prognosis of Bladder Cancer. | Int J Gen Med | 2021 | 34539184 | PubTator, text mining | PubMed |
| Follicular Helper-like T Cells in the Lung Highlight a Novel Role of B Cells in Sarcoidosis. | Am J Respir Crit Care Med | 2021 | 34534436 | PubTator, text mining | PubMed |
| TLR3 Serves as a Prognostic Biomarker and Associates with Immune Infiltration in the Renal Clear Cell Carcinoma Microenvironment. | J Oncol | 2021 | 34531911 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=45